Botulinum Toxin Non-Response: Causes

"The botox didn't take" is one of the most uncomfortable complaints in the practice. The patient feels they paid and did not receive, the professional is caught between technical doubt and pressure to inject again, and the word "resistance" comes up too early in the conversation. In practice, most failures of response to botulinum toxin have causes that are not immunological and that can be investigated with a method.

This page is a review for the professional. It does not include doses, points or protocols, which are the decision of the licensed professional, according to the product label and the rules of their professional board. The mechanism of action is in botulinum toxin in facial harmonization: fundamentals.

Primary and secondary failure: what is the difference?

The first question organizes the whole line of reasoning: did the patient never respond, or did they respond and then stop?

Separating these pictures avoids the most common mistake: treating as "resistance" what is a partial response, short duration or misaligned expectation.

What are the most common causes?

Expectation and indication

Toxin acts on the muscle. It softens dynamic wrinkles, formed by movement, but has limited effect on static wrinkles, which appear with the face at rest. A patient who expected the deep forehead furrow to disappear may read a muscle block that worked as a failure. The same applies to someone who expected to lift a drooping eyelid, slim a wide face caused by fat, or treat laxity.

Assessment too early

The onset of the effect is usually noticed within days, and the full effect is generally assessed at around two weeks. Messages on day three saying "nothing changed" are common. The usual timeline is in how long botox takes to work.

Dose and distribution

Strong musculature, such as the frontalis and the corrugator in some men, or the masseter in people who clench their teeth, may call for different planning. Parts of the muscle that fall outside the distribution stay active and give the impression that it "didn't take." Units of different products are not interchangeable, which matters when the patient switched products between one injection and the next. See differences between type A botulinum toxins.

Product, storage and reconstitution

Toxin is a sensitive protein. Heat, freezing when the label does not allow it, excessive shaking during reconstitution, use past the expiry after reconstitution and cold-chain failures can reduce potency with no visible sign on the vial. The details are in storage and cold chain of botulinum toxin.

There is also the possibility of an irregular, unregistered or counterfeit product. ANVISA (Brazil's health regulator) has already published alerts about counterfeit toxins in circulation. Buying only from an authorized supplier and checking the registration is part of prevention; see how to check an injectable's registration with ANVISA.

Neutralizing antibodies

This is the immunological cause: the body produces antibodies that neutralize the neurotoxin and reduce the response. At aesthetic doses, it is considered rare. The factors most cited in the literature are high cumulative dose, short intervals between injections and frequent top-ups a few weeks after the main injection. Labels usually advise using the lowest effective dose with the longest possible interval precisely for this reason. There is also discussion over whether the protein load of the product influences the risk; the subject is not closed.

How do you investigate in practice?

An objective sequence that fits in a follow-up visit:

1. Confirm the timing. How many days have passed since the injection? Before the assessment window, the course is to wait and advise.
2. Compare with the reference photo. Ask for the same expression as in the pre-injection photo (raised forehead, frown, forced smile) and compare with the same light and framing. Without a photo, the conversation becomes impression against impression. See standardized clinical photography.
3. Separate static from dynamic. Did the muscle stop and the furrow remain? Then it is not a toxin failure: it calls for another resource.
4. Map what still moves. A partial response usually has a pattern: a band of the frontalis, the tail of the brow, one side of the corrugator.
5. Review the record. Product, lot, expiry, reconstitution date, dose per area, interval since the previous injection and history of top-ups. All of this should be in the patient record.
6. Ask about injections elsewhere. Patients do not always say that they had a top-up with another professional or a "maintenance injection" at short intervals.
7. Assess the lot. Did other patients who received the same vial or lot respond well? If several responded poorly, suspicion falls on the product or storage.

Is there a test for resistance to toxin?

There are ways to investigate loss of response, but none is a simple routine for the practice:

When an immunological cause is strongly suspected, the most prudent path is to discuss the case with experienced colleagues or with the manufacturer's technical service, and record the decision. Alternatives such as other toxin serotypes have restricted availability and indication, and the choice depends on the health registration and label of each product.

What should you do when the response is below expectations?

The course depends on the type of failure, not on the patient's pressure:

• Before the assessment window: advise, show the timeline and schedule the follow-up.
• Partial response with a clear pattern: a top-up can be considered at reassessment, at the discretion of the licensed professional, recording the reason, product and dose. Repeated top-ups close together go into the history as a risk factor.
• Static wrinkle: explain that the muscle responded and discuss other resources, such as filler or biostimulation, if indicated.
• Suspected product or storage problem: set the lot aside, record it, contact the manufacturer and consider reporting the event. See adverse event reporting in Notivisa (Brazil's health surveillance reporting system).
• Suspected antibody: avoid successive re-injections, lengthen the intervals, document and seek specialist discussion.

Excessive effect, asymmetry and eyelid ptosis are another group of problems and are covered in complications with botulinum toxin.

How do you prevent secondary failure?

Prevention is almost all process:

1. Respect the interval between injections and avoid frequent top-ups. The usual intervals are in how often to get botox.
2. Use the lowest effective dose for the goal, with a recorded plan.
3. Buy from an authorized supplier and check the product registration.
4. Follow the label for storage, reconstitution and use-by time.
5. Photograph before and at follow-up, always in the same standard.
6. Record product, lot, dose and area at every injection.
7. Ask, at each visit, about injections done elsewhere.

How do you explain this to the patient?

The patient wants to know whether the money was lost and whether it will work next time. Be transparent about what is known and what is still to be investigated.

When reduced response over time is suspected, explain that very frequent re-injections can worsen future response and that, because of this, the interval is part of the treatment. Record the conversation and keep an informed consent that mentions the possibility of a response below expectations. A template is in consent form for botulinum toxin.

And in Harmy?

Non-response checklist

1. Assessment window respected before concluding there was a failure.
2. Pre-injection photo compared with the follow-up photo, in the same expression and light.
3. Dynamic wrinkle separated from static wrinkle.
4. Areas still active mapped and recorded.
5. Product, lot, expiry, reconstitution and storage reviewed.
6. Response of other patients from the same lot checked.
7. History of top-ups and injections elsewhere asked about.
8. Antibody hypothesis considered only after the others are ruled out.
9. Course of action, reason and conversation with the patient recorded in the patient record.